Kaleigh Fairman
Physician Assistant · Punxsutawney, PANPI 1831448737
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,378 of the $47,463 with a category attached, or 66.1%. AbbVie accounts for 75.2% of it on its own, with 48 other manufacturers making up the rest. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,080 payments — averaging $43.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$36K
- Teva Pharmaceuticals USA, Inc.$4K
- Biogen$2K
- UCB, Inc.$593
- Biohaven Pharmaceutical Holding Company Ltd.$535
- Pfizer$518
- plus $4K from 43 others
What the payments were for
- Consulting fees$4501%
- Speaking & faculty fees$31,37866%
- Travel & lodging$3051%
- Food & beverage$14,96332%
- Education$3671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,463 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 44 | $440,095 |
| VumerityDiroximel Fumarate | 25 | $255,723 |
| AustedoDeutetrabenazine | 24 | $233,924 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 36 | $192,600 |
| Nurtec OdtRimegepant Sulfate | 135 | $158,349 |
| TecfideraDimethyl Fumarate | 13 | $120,814 |
| CopaxoneGlatiramer Acetate | 17 | $103,725 |
| Emgality PenGalcanezumab-Gnlm | 103 | $78,735 |
| Austedo XrDeutetrabenazine | 16 | $76,901 |
| QuliptaAtogepant | 52 | $56,783 |
| Aimovig AutoinjectorErenumab-Aooe | 73 | $51,028 |
| BriviactBrivaracetam | 27 | $38,124 |
| BotoxOnabotulinumtoxina | 26 | $32,225 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 40 | $27,710 |
| Glatiramer Acetate | 11 | $21,132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt | $518 | $598,444179 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Copaxone, Austedo Xr | $3,822 | $414,55057 claims |
| BiogenVumerity, Tecfidera | $1,884 | $376,53738 claims |
| AbbVieQulipta, Botox, Ubrelvy | $35,701 | $104,36994 claims |
| UCB, Inc.Briviact | $593 | $38,12427 claims |
| Upsher-smith Laboratories LLCTopiramate | $74 | $2,302326 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $58 | $1,58824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Punxsutawney
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.